Travere Therapeutics Announces R&D Leadership Transition Plan

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mornings like we had on Wednesday are exactly why I get up and ...

Nuvectis gains two experimental drugs in licensing deal with China's Haisco

June 22 () - Nuvectis Pharma said on Monday it had licensed exclusive rights outside China to two experimental drugs from ‌Haisco Pharmaceutical Group, targeting complement-mediated diseases and ...

Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?

Compare risk profiles, sector concentration, and income potential as these two healthcare ETFs take different approaches to ...